Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer. | Cancers (Basel) | 2023 | 37835536 | PubTator, text mining | PubMed |
| Anticancer effects of gossypetin from Hibiscus sabdariffa in oral squamous cell carcinoma. | J Appl Oral Sci | 2023 | 37820185 | PubTator, text mining | PubMed |
| The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies. | Front Pharmacol | 2023 | 37818196 | PubTator, text mining | PubMed |
| Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. | Front Oncol | 2023 | 37810967 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Complex Cell-Cell Communication Networks in the Mouse Cornea. | Invest Ophthalmol Vis Sci | 2023 | 37792336 | PubTator, text mining | PubMed |
| Impact of somatic mutations and transcriptomic alterations on cancer aneuploidy. | Biomed Res | 2023 | 37779031 | PubTator, text mining | PubMed |
| Adipose‑derived stem cell‑mediated alphastatin targeting delivery system inhibits angiogenesis and tumor growth in glioma. | Mol Med Rep | 2023 | 37772382 | PubTator, text mining | PubMed |
| Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment. | Microorganisms | 2023 | 37764013 | PubTator, text mining | PubMed |
| Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation. | Medicina (Kaunas) | 2023 | 37763758 | PubTator, text mining | PubMed |
| A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer. | Int J Mol Sci | 2023 | 37762693 | PubTator, text mining | PubMed |
| Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies. | Cancers (Basel) | 2023 | 37760631 | PubTator, text mining | PubMed |
| Gossypetin Is a Novel Modulator of Inflammatory Cytokine Production and a Suppressor of Osteosarcoma Cell Growth. | Antioxidants (Basel) | 2023 | 37760046 | PubTator, text mining | PubMed |
| Transformer-Based Multi-Modal Data Fusion Method for COPD Classification and Physiological and Biochemical Indicators Identification. | Biomolecules | 2023 | 37759791 | PubTator, text mining | PubMed |
| Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods. | BioData Min | 2023 | 37752578 | PubTator, text mining | PubMed |
| mRNA vaccines in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37726283 | PubTator, text mining | PubMed |
| Identification of early diagnostic biomarkers for breast cancer through bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37713876 | PubTator, text mining | PubMed |
| Prognostic value of cell division cycle-associated protein-3 in prostate cancer. | Medicine (Baltimore) | 2023 | 37682152 | PubTator, text mining | PubMed |
| Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. | PLoS Pathog | 2023 | 37669313 | PubTator, text mining | PubMed |
| Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma. | PeerJ | 2023 | 37663298 | PubTator, text mining | PubMed |
| Lysosome-related genes: A new prognostic marker for lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37657029 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=10